M. Beck

699 total citations
20 papers, 203 citations indexed

About

M. Beck is a scholar working on Surgery, Immunology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M. Beck has authored 20 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Immunology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M. Beck's work include Biosimilars and Bioanalytical Methods (5 papers), Hernia repair and management (5 papers) and Pharmaceutical studies and practices (4 papers). M. Beck is often cited by papers focused on Biosimilars and Bioanalytical Methods (5 papers), Hernia repair and management (5 papers) and Pharmaceutical studies and practices (4 papers). M. Beck collaborates with scholars based in France, Pakistan and New Zealand. M. Beck's co-authors include Bruno Michel, Christelle Sordet, Jean Sibilia, Michel Velten, Dominique Levêque, Sarah Lewit, B. Gourieux, Jean-David Cohen, Geneviève Ubeaud-Séquier and Guillaume Becker and has published in prestigious journals such as International Journal of Pharmaceutics, International Journal for Quality in Health Care and mAbs.

In The Last Decade

M. Beck

17 papers receiving 195 citations

Peers

M. Beck
Genia Long United States
Lisa A. Fulchino United States
Ott Laius Estonia
Aisha Vadhariya United States
Matthew T. Taylor United States
ChangWon C. Lee United States
Genia Long United States
M. Beck
Citations per year, relative to M. Beck M. Beck (= 1×) peers Genia Long

Countries citing papers authored by M. Beck

Since Specialization
Citations

This map shows the geographic impact of M. Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Beck more than expected).

Fields of papers citing papers by M. Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Beck. The network helps show where M. Beck may publish in the future.

Co-authorship network of co-authors of M. Beck

This figure shows the co-authorship network connecting the top 25 collaborators of M. Beck. A scholar is included among the top collaborators of M. Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Beck. M. Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beck, M., et al.. (2023). Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review. European Journal of Hospital Pharmacy. 31(4). 289–294. 6 indexed citations
4.
Delon, Claire, et al.. (2020). Adherence to oral anticancer chemotherapies and estimation of the economic burden associated with unused medicines. International Journal of Clinical Pharmacy. 42(5). 1311–1318. 2 indexed citations
5.
Cohen, Jean-David, et al.. (2019). Patients’ information and perspectives on biosimilars in rheumatology: A French nation-wide survey. Joint Bone Spine. 86(4). 491–496. 34 indexed citations
7.
8.
Michel, Bruno, et al.. (2016). Drug-dispensing problems community pharmacists face when patients are discharged from hospitals: a study about 537 prescriptions in Alsace. International Journal for Quality in Health Care. 28(6). 779–784. 10 indexed citations
9.
Beck, M., et al.. (2016). Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings?. European Journal of Hospital Pharmacy. 24(2). 85–90. 8 indexed citations
10.
Beck, M., et al.. (2016). A UV-Raman spectrometry method for quality control of anticancer preparations: Results after 18 months of implementation in hospital pharmacy. International Journal of Pharmaceutics. 499(1-2). 343–350. 25 indexed citations
11.
Beck, M., Bruno Michel, Dominique Levêque, et al.. (2016). Rheumatologists’ Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey. BioDrugs. 30(6). 585–592. 44 indexed citations
12.
Beck, M., et al.. (2016). Tratamiento de las hernias inguinales estranguladas. 32(1). 1–9.
13.
Beck, M., Bruno Michel, Dominique Levêque, et al.. (2016). Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey. mAbs. 9(2). 384–391. 40 indexed citations
14.
Beck, M., et al.. (2015). Cartographie des risques liés à la prise en charge médicamenteuse en EHPAD : état des lieux en région Alsace – France. Revue d Épidémiologie et de Santé Publique. 63(3). 163–172. 5 indexed citations
16.
Beck, M.. (2011). Perineal hernia: The ventral decubitus perineal approach. Journal of Visceral Surgery. 148(1). 39–41. 3 indexed citations
17.
Beck, M., L. Bresler, & Pascal Breil. (2010). Opération de Heller pour mégaœsophage idiopathique. 27(4). 1–13. 1 indexed citations
18.
Beck, M.. (2008). Traitement des grandes éventrations médianes par autoplastie et alloplastie rétromusculaire. Journal de Chirurgie. 145(5). 475–477. 1 indexed citations
19.
Beck, M., et al.. (2000). 10.1016/s0246-0424(22)43306-1. Time to knit. 2 indexed citations
20.
Beck, M., et al.. (1969). Abortion: a national public and mental health problem-past, present, and proposed research.. American Journal of Public Health and the Nations Health. 59(12). 2131–2143. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026